Discover insights from thousands of peer-reviewed papers on microbial electrochemical systems
Ankur Sharma, Dhruv Kumar, Kajal Dahiya et al.
Nanomedicine · 2021
The increasing burden of respiratory diseases caused by microbial infections poses an immense threat to global health. This review focuses on the various types of biofilms that affect the respiratory system and cause pulmonary infections, specifically bacterial biofilms. The article also sheds light on the current strategies employed for the treatment of such pulmonary infection-causing biofilms. The potential of nanocarriers as an effective treatment modality for pulmonary infections is discussed, along with the challenges faced during treatment and the measures that may be implemented to overcome these. Understanding the primary approaches of treatment against biofilm infection and applications of drug-delivery systems that employ nanoparticle-based approaches in the disruption of biofilms are of utmost interest which may guide scientists to explore the vistas of biofilm research while determining suitable treatment modalities for pulmonary respiratory infections.
K. Sachin, S. K. Karn
Frontiers in Chemistry · 2021
The emergence of nanosystems for different biomedical and drug delivery applications has drawn the attention of researchers worldwide. The likeness of microorganisms including bacteria, yeast, algae, fungi, and even viruses toward metals is well-known. Higher tolerance to toxic metals has opened up new avenues of designing microbial fabricated nanomaterials. Their synthesis, characterization and applications in bioremediation, biomineralization, and as a chelating agent has been well-documented and reviewed. Further, these materials, due to their ability to get functionalized, can also be used as theranostics i.e., both therapeutic as well as diagnostic agents in a single unit. Current article attempts to focus particularly on the application of such microbially derived nanoformulations as a drug delivery and targeting agent. Besides metal-based nanoparticles, there is enough evidence wherein nanoparticles have been formulated using only the organic component of microorganisms. Enzymes, peptides, polysaccharides, polyhydroxyalkanoate (PHA), poly-(amino acids) are amongst the most used biomolecules for guiding crystal growth and as a capping/reducing agent in the fabrication of nanoparticles. This has promulgated the idea of complete green chemistry biosynthesis of nano-organics that are most sought after in terms of their biocompatibility and bioavailability.
A. Shariati, Z. Chegini, E. Ghaznavi-Rad et al.
Frontiers in Cellular and Infection Microbiology · 2022
The biofilm community of microorganisms has been identified as the dominant mode of microbial growth in nature and a common characteristic of different microorganisms such as Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis. The biofilm structure helps in the protection from environmental threats including host immune system and antimicrobial agents. Thus, the biofilm community has led to a higher prevalence of multidrug-resistant (MDR) strains in recent years. In this regard, the use of a new class of antibiotics, natural compounds, and anti-biofilm enzymes has been considered for the destruction of the microbial biofilm. However, different drawbacks such as low penetration, high susceptibility to degradation, instability, and poor solubility in aqueous solutions limit the use of anti-biofilm agents (ABAs) in a clinical setting. As such, recent studies have been using poly lactic-co-glycolic acid (PLGA)-based nanoplatforms (PLGA NPFs) for delivery of ABAs that have reported promising results. These particles, due to proper drug loading and release kinetics, could suppress microbial attachment, colonization, and biofilm formation for a long time. Additionally, PLGA NPFs, because of the high drug-loading efficiencies, hydrophilic surface, negative charge, and electrostatic interaction, lead to effective penetration of antibiotics to the deeper layer of the biofilm, thereby eliminating the microbial biofilm. Thus, PLGA NPFs could be considered as a potential candidate for coating catheters and other medical material surfaces for inhibition and destruction of the microbial biofilm. However, the exact interaction of PLGA NPFs and the microbial biofilm should be evaluated in animal studies. Additionally, a future goal will be to develop PLGA formulations as systems that can be used for the treatment of the MDR microbial biofilm, since the exact interactions of PLGA NPFs and these biofilm structures are not elucidated. In the present review article, we have discussed various aspects of PLGA usage for inhibition and destruction of the microbial biofilm along with different methods and procedures that have been used for improving PLGA NPF efficacy against the microbial biofilm.
P. Gotovtsev
Biomimetics · 2023
The presented review focused on the microbial cell based system. This approach is based on the application of microorganisms as the main part of a robot that is responsible for the motility, cargo shipping, and in some cases, the production of useful chemicals. Living cells in such microrobots have both advantages and disadvantages. Regarding the advantages, it is necessary to mention the motility of cells, which can be natural chemotaxis or phototaxis, depending on the organism. There are approaches to make cells magnetotactic by adding nanoparticles to their surface. Today, the results of the development of such microrobots have been widely discussed. It has been shown that there is a possibility of combining different types of taxis to enhance the control level of the microrobots based on the microorganisms’ cells and the efficiency of the solving task. Another advantage is the possibility of applying the whole potential of synthetic biology to make the behavior of the cells more controllable and complex. Biosynthesis of the cargo, advanced sensing, on/off switches, and other promising approaches are discussed within the context of the application for the microrobots. Thus, a synthetic biology application offers significant perspectives on microbial cell based microrobot development. Disadvantages that follow from the nature of microbial cells such as the number of external factors influence the cells, potential immune reaction, etc. They provide several limitations in the application, but do not decrease the bright perspectives of microrobots based on the cells of the microorganisms.
M. Puccetti, M. Pariano, P. Wojtyło et al.
Pharmaceutics · 2023
Developing therapeutics for inflammatory diseases is challenging due to physiological mucosal barriers, systemic side effects, and the local microbiota. In the search for novel methods to overcome some of these problems, drug delivery systems that improve tissue-targeted drug delivery and modulate the microbiota are highly desirable. Microbial metabolites are known to regulate immune responses, an observation that has resulted in important conceptual advances in areas such as metabolite pharmacology and metabolite therapeutics. Indeed, the doctrine of “one molecule, one target, one disease” that has dominated the pharmaceutical industry in the 20th century is being replaced by developing therapeutics which simultaneously manipulate multiple targets through novel formulation approaches, including the multitarget-directed ligands. Thus, metabolites may not only represent biomarkers for disease development, but also, being causally linked to human diseases, an unexploited source of therapeutics. We have shown the successful exploitation of this approach: by deciphering how signaling molecules, such as the microbial metabolite, indole-3-aldehyde, and the repurposed drug anakinra, interact with the aryl hydrocarbon receptor may pave the way for novel therapeutics in inflammatory human diseases, for the realization of which drug delivery platforms are instrumental.
Heli Siti Halimatul Munawaroh, B. Anwar, G. Yuliani et al.
Bioengineered · 2023
ABSTRACT Phycocyanin, produced by Spirulina platensis, has been reported as an anti-inflammatory, anti-hyperalgesia, antioxidant, anti-tumor, and anti-cancer agent. However, the ingestion of phycocyanin in the body is often hindered by its instability against gastric pH conditions. The nano-drug delivery system has developed as a promising platform for efficient drug delivery and improvement as well as drug efficacy. Bacterial cellulose nanocrystal (BCNC) has it superiority as DDS due to its inherent properties such as nanoscale dimension, large surface area, - biocompatibility, and non-toxic. To improve its mechanical properties, BCNC was crosslinked with glutaraldehyde and was analyzed as a potential candidate for DDS. The Fourier transform infrared analysis of the BCNC suggested that hydrolysis did not alter the chemical composition. The index of crystallinity of the BCNC was 18.31% higher than that of the original BC, suggesting that crystalline BC has been successfully isolated. The BCNC particle also showed a needle-like morphology which is 25 ± 10 nm in diameter and a mean length of 626 ± 172 nm. Crosslinked BCNC also had larger pores than the original BCNC along with higher thermal stability. Optimum phycocyanin adsorption on crosslinked BCNC reached 65.3% in 3 h. The release study shows that the crosslinked BCNC can protect the phycocyanin retardation by gastric fluid until phycocyanin reaches the targeted sites. This study provides an alternative potential DDS derived from natural bioresources with less expenses and better properties to promote the application of BCNC as functional nanomaterials in biomedical science.
Tongjiang He, Zhendong Zhao, Zhentao Luo et al.
Acta Materia Medica · 2023
Microorganisms are mostly distributed on the surface of our skin and intestines and have crucial roles in physiologic and metabolic processes, such as digestion and immunity, which are closely related to diseases. Recently, microorganisms have received great attention and have been applied in various aspects of biomedicine, especially in the field of drug delivery. However, the application of bacteria has been largely limited due to the intrinsic nature of bacteria, including rapid proliferation, toxicity, and immunogenicity. Therefore, microbial decoration is an attention-grabbing approach to drug delivery by altering the properties and functions of microbial surfaces. Microbial decoration methods are diverse and include biotin-affinity and gene decoration technologies. These approaches can improve the specific delivery of drugs, enhance the stability and controlled release of drug delivery vehicles, and are useful in cancer therapy, gene therapy, and vaccine delivery. Microbial decoration has broad application prospects by helping develop smarter and more precise drug delivery systems and providing more effective and safer therapeutic options for patients. In this review we summarize the research progress in different microbial surface modification methods and the applications in drug delivery, as well as the outlook for future opportunities in this field.
Aigerim Yermagambetova, S. Tazhibayeva, P. Takhistov et al.
Polymers · 2024
This review examines microbial polysaccharides’ properties relevant to their use in packaging and pharmaceutical applications. Microbial polysaccharides are produced by enzymes found in the cell walls of microbes. Xanthan gum, curdlan gum, pullulan, and bacterial cellulose are high-molecular-weight substances consisting of sugar residues linked by glycoside bonds. These polysaccharides have linear or highly branched molecular structures. Packaging based on microbial polysaccharides is readily biodegradable and can be considered as a renewable energy source with the potential to reduce environmental impact. In addition, microbial polysaccharides have antioxidant and prebiotic properties. The physico-chemical properties of microbial polysaccharide-based films, including tensile strength and elongation at break, are also evaluated. These materials’ potential as multifunctional packaging solutions in the food industry is demonstrated. In addition, their possible use in medicine as a drug delivery system is also considered.
Chenyu Zong, Fei Wang, Wenguo Cui
Research · 2025
In situ microbial aerodynamic microneedles (MM-MNs) represent an autonomous transdermal drug delivery platform that utilizes the gas generated by microbial metabolism (e.g., H 2 , NO, and H 2 S) to propel drugs into deep tissues, surpassing the penetration limits of traditional microneedles reliant on external stimuli (heat/light/mechanical force). By leveraging controlled microbial metabolism, MM-MNs enable energy-independent, spatiotemporally precise delivery with enhanced targeting and bioavailability. Gas-driven propulsion combines with bioactive gas functions (e.g., NO-induced vasodilation and H 2 S-mediated anti-inflammation) to modulate disease microenvironments. The system’s biocompatibility (probiotic strains and Lactobacillus ) and scalability (cost-effective patch design) further support its potential for localized therapies (skin diseases and tumors) with minimized systemic exposure. This innovation bridges microbial biotechnology and precision medicine, offering a paradigm shift in transdermal delivery.
Yasutaka Shimizu, J. Fastier-Wooller, Yoshihiro Muneta et al.
2024 IEEE SENSORS · 2024
Long term diagnostics and health monitoring of inaccessible sensors require strenuous power management or alternate power generation methods. Intraruminal devices can be powered with green energy using a microbial fuel cell (MFC). However, issues concerning poor steady-state power generation in anaerobic environments must be addressed. In this study, we propose a new type of structure of MFC for power generation in the rumen of cattle. Steady-state performance is evaluated with electrodes of 3 different materials. Using our proposed structure, the MFC's voltage drop in anaerobic environments is minimized, and each material electrode displayed a maximum power generation characteristic as follows: 0.4 µW/cm2 for gold, 0.15 µW/cm2 for platinum, and 0.002 µW/cm2 for carbon.
Lin Liu, Seokheun Choi
SLAS Technology · 2019
A merged system incorporating paperfluidics and papertronics has recently emerged as a simple, single-use, low-cost paradigm for disposable point-of-care (POC) diagnostic applications. Stand-alone and self-sustained paper-based systems are essential to providing effective and lifesaving treatments in resource-constrained environments. Therefore, a realistic and accessible power source is required for actual paper-based POC systems as their diagnostic performance and portability rely significantly on power availability. Among many paper-based batteries and energy storage devices, paper-based microbial fuel cells have attracted much attention because bacteria can harvest electricity from any type of organic matter that is readily available in those challenging regions. However, the promise of this technology has not been translated into practical power applications because of its short power duration, which is not enough to fully operate those systems for a relatively long period. In this work, we for the first time demonstrate a simple and long-lasting paper-based biological solar cell that uses photosynthetic bacteria as biocatalysts. The bacterial photosynthesis and respiration continuously and self-sustainably generate power by converting light energy into electricity. With a highly porous and conductive anode and an innovative solid-state cathode, the biological solar cell built upon the paper substrates generated the maximum current and power density of 65 µA/cm2 and 10.7 µW/cm2, respectively, which are considerably greater than those of conventional micro-sized biological solar cells. Furthermore, photosynthetic bacteria in a 3-D volumetric chamber made of a stack of papers provided stable and long-lasting electricity for more than 5 h, while electrical current from the heterotrophic culture on 2-D paper dramatically decreased within several minutes.
Anwar Elhadad, Yang Gao, Seokheun Choi
Advanced Materials Technologies · 2023
Single‐use electrical systems represent the future of multiple fields such as diagnostic medical technologies, environmental studies, and biofuel manufacturing with significant advantages over conventional unrecyclable bulky systems that are partly disposable at best. Single‐use systems require miniaturized bio‐friendly energy sources that meet the recyclability or reusability requirement of the application without creating toxic waste. Herein, a storable, scalable, and single‐use electronics‐compatible bio‐battery that is designed and fabricated using completely reusable and recyclable components is developed. The battery is a dual‐in‐line package microbial fuel cell (DIP‐MFC) that can be activated on demand via the introduction of moisture through the anodic fluid chamber. The battery incorporates dormant bacteria cells on an abiotic stainless steel mesh that serves as the anode that attracts electrons being transferred from the biocatalyst. The DIP‐MFC uses the infestation of bacterial biofilm on a conductive anode to harness electrons and deliver electricity to selected circuit pins. A single DIP‐MFC continuously operates for 140 min with a maximum open circuit voltage of 0.55 V, which can be stacked and connected to match the power requirements of targeted electronics. The DIP nature of the proposed bio‐battery allows for simple integration of the MFC on conventional electronics boards through conductive pins.
Chloé Grazon, R. Baer, Uroš Kuzmanović et al.
Nature Communications · 2020
Bacteria are an enormous and largely untapped reservoir of biosensing proteins. We describe an approach to identify and isolate bacterial allosteric transcription factors (aTFs) that recognize a target analyte and to develop these TFs into biosensor devices. Our approach utilizes a combination of genomic screens and functional assays to identify and isolate biosensing TFs, and a quantum-dot Förster Resonance Energy Transfer (FRET) strategy for transducing analyte recognition into real-time quantitative measurements. We use this approach to identify a progesterone-sensing bacterial aTF and to develop this TF into an optical sensor for progesterone. The sensor detects progesterone in artificial urine with sufficient sensitivity and specificity for clinical use, while being compatible with an inexpensive and portable electronic reader for point-of-care applications. Our results provide proof-of-concept for a paradigm of microbially-derived biosensors adaptable to inexpensive, real-time sensor devices. Bacteria represent an unexploited reservoir of biosensing proteins. Here the authors use genomic screens and functional assays to isolate a progesterone sensing allosteric transcription factor and use a FRET-based method to develop an optical progesterone sensor.
A. Kharkova, V. A. Arlyapov, Anastasia Medvedeva et al.
Sensors · 2022
Microbial mediator biosensors for surface water toxicity determination make it possible to carry out an early assessment of the environmental object’s quality without time-consuming standard procedures based on standard test-organisms, and provide broad opportunities for receptor element modifying depending on the required operational parameters analyzer. Four microorganisms with broad substrate specificity and nine electron acceptors were used to form a receptor system for toxicity assessment. Ferrocene was the most effective mediator according to its high rate constant of interaction with the microorganisms (0.33 ± 0.01 dm3/(g × s) for yeast Saccharomyces cerevisiae). Biosensors were tested on samples containing four heavy metal ions (Cu2+, Zn2+, Pb2+, Cd2+), two phenols (phenol and p-nitrophenol), and three natural water samples. The «ferrocene- Escherichia coli» and «ferrocene-Paracoccus yeei, E. coli association» systems showed good operational stability with a relative standard deviation of 6.9 and 7.3% (14 measurements) and a reproducibility of 7 and 5.2% using copper (II) ions as a reference toxicant. Biosensor analysis with these systems was shown to highly correlate with the results of the standard method using Chlorella algae as a test object. Developed biosensors allow for a valuation of the polluted natural water’s impact on the ecosystem via an assessment of the influence on bacteria and yeast in the receptor system. The systems could be used in toxicological monitoring of natural waters.
Caitlin Crews-Stowe, Elizabeth Lambert, Lori Berthelot et al.
Antimicrobial Stewardship & Healthcare Epidemiology · 2023
Background: Healthcare floors are a vehicle and/or source for potential pathogens that cause healthcare associated infections, and hospital floors are often heavily contaminated with pathogens such as Clostridioides difficile and methicillin-resistant Staphylococcus aureus. However, definitive research linking reductions in floor burden to reductions in HAIs has not yet been established. We sought to evaluate emerging technology for continuous disinfection and its potential impact on HAIs. This study was designed to explore the potential relationship between the reduction of microbial burden of floors and healthcare associated infections. Methods: A prospective study was conducted in a 22-bed medical-surgical intensive care unit in a 180-bed suburban hospital near New Orleans, Louisiana, from November 2021 to June 2022. Using sterile, premoistened sponges, samples were collected from the floors of 10 areas throughout the unit including 2 nurses’ stations, the physician charting area, and 7 patient rooms. The advanced photocatalytic oxidation (aPCO) equipment was then installed in the HVAC ductwork throughout the ICU and activated. Environmental surface sampling of the same floor surfaces was then repeated every 4 weeks for the first 5 months of the study. HAIs were also tracked throughout the entire study period. The facility’s normal cleaning floor protocols using a neutralizing floor cleaner were unchanged and followed during the study. Changes in surface burden were calculated using a repeated-methods ANOVA with post hoc analyses as appropriate. Rates of healthcare associated infections were compared using χ2 analyses. Results: Overall, there was a 99.6% statistically significant decrease in floor environmental surface burden from the baseline to the final postactivation test (Fig. 1). The average colony forming unit count (CFU) decreased from 318,850 CFU per 100 cm2 to just 2,988 CFU per 100 cm2. The unit also saw a statistically significant decrease in publicly reported healthcare associated infections (HO-MRSA, CLABSI, HO-CDI) during the study period compared to the same period a year prior and in the 6 months immediately prior to the beginning of the study (Fig. 2). Conclusions: Advanced photocatalytic oxidation technology resulted in a reduction of microbial burden on the floors of a high-traffic intensive care unit. Statistically significant decreases in healthcare-associated infections was also seen. This study highlights a novel aPCO technology and its efficacy at reducing microbial burden and healthcare-associated infections despite no change in practice. Disclosures: None
A. Costello, J. Parker, M. Clynes et al.
Metallomics · 2020
The modern world has seen exposure of bacterial communities to toxic metals at selective levels. This manifests itself both intentionally, through medicines and un-intentionally through waste streams. There is growing concern that selective exposure to metals may be linked to microbial resistance to antibiotics. For a microbe to become resistant to a specific metal it must first come in contact with it. The transition metal copper has the ability to enter bacterial cells without need for a copper specific uptake mechanism. Copper is commonly used as an antimicrobial in the healthcare industry, consumer products and as a growth promoter of livestock in the agricultural sector. Here we report a study into the uptake of different organic and inorganic sources of copper. A whole-cell bacterial biosensor was developed to quantify the specific uptake of copper from various sources. Furthermore, a cell-free sensor was utilized to investigate the response to copper sources when uptake is eliminated as a factor. The data within suggest inorganic copper to have greatly reduced uptake compared to organic sources and that there is significant difference between copper oxides, Cu2O and CuO.
R. Funari, A. Shen
ACS Sensors · 2022
Microbial biofilms have caused serious concerns in healthcare, medical, and food industries because of their intrinsic resistance against conventional antibiotics and cleaning procedures and their capability to firmly adhere on surfaces for persistent contamination. These global issues strongly motivate researchers to develop novel methodologies to investigate the kinetics underlying biofilm formation, to understand the response of the biofilm with different chemical and physical treatments, and to identify biofilm-specific drugs with high-throughput screenings. Meanwhile microbial biofilms can also be utilized positively as sensing elements in cell-based sensors due to their strong adhesion on surfaces. In this perspective, we provide an overview on the connections between sensing and microbial biofilms, focusing on tools used to investigate biofilm properties, kinetics, and their response to chemicals or physical agents, and biofilm-based sensors, a type of biosensor using the bacterial biofilm as a biorecognition element to capture the presence of the target of interest by measuring the metabolic activity of the immobilized microbial cells. Finally we discuss possible new research directions for the development of robust and rapid biofilm related sensors with high temporal and spatial resolutions, pertinent to a wide range of applications.
S. Bobade, D. Kalorey, S. Warke
Bioscience Biotechnology Research Communications · 2016
The natural biosensors are chemical sense organs specially designed on the basis of smell and taste likewise. Biosensor is a device that detects, transmits and records information regarding physiological or biochemical changes. Basically it is the probe that integrates a biological component with an electronic transducer thereby converting biochemical signals into electrochemical, optical, acoustic and electronic ones. The function of a biosensor depends on specifi city of biological active material and the analyte to be detected such as chemical compound, antigen, microbes, hormones, nucleic acid or any subjective parameter like smell and taste. The biological sensing elements have been used as enzyme, antibody, DNA ,receptor ,organelles and micro-organism as well as animal and plant tissues. Types of biosensor includes immunosensors, microbial biosensors, whole cell based, electrochemical, optical and acoustic biosensors, which have vast applications in biomedical research, healthcare, pharmaceutical, environmental monitoring, homemade security and battlefi elds. In this review a summary of relevant aspects concerning biosensor integration in effi cient analytical setups and the latest applications of biosensors in diagnostic applications focusing on detection of molecular biomarkers in real samples is included. An overview of the current state and future trends of biosensors in this fi eld is given.
Taeho Yu, Minjee Chae, Ziling Wang et al.
Microbial Biotechnology · 2025
ABSTRACT The combination of artificial intelligence (AI) with microbial technology marks the start of a major transformation, improving applications throughout biotechnology, especially in healthcare. With the capability of AI to process vast amounts of biological big data, advanced microbial technology allows for a comprehensive understanding of complex biological systems, advancing disease diagnosis, treatment and the development of microbial therapeutics. This mini review explores the impact of AI‐integrated microbial technologies in healthcare, highlighting advancements in microbial biomarker‐based diagnosis, the development of microbial therapeutics and the microbial production of therapeutic compounds. This exploration promises significant improvements in the design and implementation of health‐related solutions, steering a new era in biotechnological applications.
Tuoyu Zhou, Huawen Han, Pu Liu et al.
Sensors · 2017
With the unprecedented deterioration of environmental quality, rapid recognition of toxic compounds is paramount for performing in situ real-time monitoring. Although several analytical techniques based on electrochemistry or biosensors have been developed for the detection of toxic compounds, most of them are time-consuming, inaccurate, or cumbersome for practical applications. More recently, microbial fuel cell (MFC)-based biosensors have drawn increasing interest due to their sustainability and cost-effectiveness, with applications ranging from the monitoring of anaerobic digestion process parameters (VFA) to water quality detection (e.g., COD, BOD). When a MFC runs under correct conditions, the voltage generated is correlated with the amount of a given substrate. Based on this linear relationship, several studies have demonstrated that MFC-based biosensors could detect heavy metals such as copper, chromium, or zinc, as well as organic compounds, including p-nitrophenol (PNP), formaldehyde and levofloxacin. Both bacterial consortia and single strains can be used to develop MFC-based biosensors. Biosensors with single strains show several advantages over systems integrating bacterial consortia, such as selectivity and stability. One of the limitations of such sensors is that the detection range usually exceeds the actual pollution level. Therefore, improving their sensitivity is the most important for widespread application. Nonetheless, MFC-based biosensors represent a promising approach towards single pollutant detection.
Z. N. Temirzhanova
Bulletin of Shakarim University. Technical Sciences · 2023
In this review, we discussed the design and manufacture of point-of-care test (POST) devices for the detection of microbial pathogens, including bacteria, viruses, fungi, and parasites. Electrochemical methods and current advances in the field were highlighted in terms of integrated electrochemical platforms, which include mainly microfluidic based approaches and integrated smartphone and Internet of things (IoM) and internet of medical things (IoMT) systems. In addition, the availability of commercial biosensors for the detection of microbial pathogens will be reported. At the end, challenges in point-of-care (POC) biosensor fabrication and expected future advances in biosensor technology were discussed. Integrated biosensor-based platforms with IoM/IoMT typically collect data to track the spread of infectious diseases in the community, which would be useful in terms of better preparedness for current and future pandemics and is expected to prevent social and economic losses. In the last decade, the science of biosensors has made tremendous progress in diagnosing diseases. Drug-resistant bacteria are outperforming drug discovery efforts, jeopardizing modern antibiotics and threatening many inevitable medical procedures that are taken for granted. Combating this worldwide threat will require the invention and application of ever-wider diagnostics of infectious diseases.
E. D. Di Domenico, A. Oliva, M. Guembe
Microorganisms · 2022
Biofilm is the trigger for the majority of infections caused by the ability of microorganisms to adhere to tissues and medical devices. Microbial cells embedded in the biofilm matrix are highly tolerant to antimicrobials and escape the host immune system. Thus, the refractory nature of biofilm-related infections (BRIs) still represents a great challenge for physicians and is a serious health threat worldwide. Despite its importance, the microbiological diagnosis of a BRI is still difficult and not routinely assessed in clinical microbiology. Moreover, biofilm bacteria are up to 100–1000 times less susceptible to antibiotics than their planktonic counterpart. Consequently, conventional antibiograms might not be representative of the bacterial drug susceptibility in vivo. The timely recognition of a BRI is a crucial step to directing the most appropriate biofilm-targeted antimicrobial strategy.
M. Mihai, A. Holban, C. Giurcaneanu et al.
Current Topics in Medicinal Chemistry · 2015
The majority of chronic infections are associated with mono- or polymicrobial biofilms, having a significant impact on the patients' quality of life and survival rates. Although the use of medical devices revolutionized health care services and significantly improved patient outcomes, it also led to complications associated with biofilms and to the emergence of multidrug resistant bacteria. Immunocompromised patients, institutionalized or hospitalized individuals, elderly people are at greater risk due to life-threatening septic complications, but immunocompetent individuals with predisposing genetic or acquired diseases can also be affected, almost any body part being able to shelter persistent biofilms. Moreover, chronic biofilm-related infections can lead to the occurrence of systemic diseases, as in the case of chronic periodontitis, linked to atherosclerosis, cardiovascular disease and diabetes. The more researchers discover, new unknown issues add up to the complexity of biofilm infections, in which microbial species establish relationships of cooperation and competition, and elaborate phenotypic differentiation into functional, adapted communities. Their interaction with the host's immune system or with therapeutic agents contributes to the complex puzzle that still misses a lot of pieces. In this comprehensive review we aimed to highlight the microbial composition, developmental stages, architecture and properties of medical biofilms, as well as the diagnostic tools used in the management of biofilm related infections. Also, we present recently acquired knowledge on the etiopathogenesis, diagnosis and treatment of four chronic diseases associated with biofilm development in tissues (chronic periodontitis, chronic lung infection in cystic fibrosis, chronic wounds) and artificial substrata (medical devices-related infections).
R. Žalnėravičius, A. Paškevičius, U. Samukaite-Bubniene et al.
Biosensors · 2022
In this study, the nitrogen-fixing, Gram-negative soil bacteria Rhizobium anhuiense was successfully utilized as the main biocatalyst in a bacteria-based microbial fuel cell (MFC) device. This research investigates the double-chambered, H-type R. anhuiense-based MFC that was operated in modified Norris medium (pH = 7) under ambient conditions using potassium ferricyanide as an electron acceptor in the cathodic compartment. The designed MFC exhibited an open-circuit voltage (OCV) of 635 mV and a power output of 1.07 mW m−2 with its maximum power registered at 245 mV. These values were further enhanced by re-feeding the anode bath with 25 mM glucose, which has been utilized herein as the main carbon source. This substrate addition led to better performance of the constructed MFC with a power output of 2.59 mW m−2 estimated at an operating voltage of 281 mV. The R. anhuiense-based MFC was further developed by improving the charge transfer through the bacterial cell membrane by applying 2-methyl-1,4-naphthoquinone (menadione, MD) as a soluble redox mediator. The MD-mediated MFC device showed better performance, resulting in a slightly higher OCV value of 683 mV and an almost five-fold increase in power density to 4.93 mW cm−2. The influence of different concentrations of MD on the viability of R. anhuiense bacteria was investigated by estimating the optical density at 600 nm (OD600) and comparing the obtained results with the control aliquot. The results show that lower concentrations of MD, ranging from 1 to 10 μM, can be successfully used in an anode compartment in which R. anhuiense bacteria cells remain viable and act as a main biocatalyst for MFC applications.
T. Kremer, Jeff Felgar, Neil Rowen et al.
Biomedical Instrumentation & Technology · 2023
The identification of worst-case device (or device set) features has been a well-established validation approach in many areas (e.g., terminal sterilization) for determining process effectiveness and requirements, including for reusable medical devices. A device feature approach for cleaning validations has many advantages, representing a more conservative approach compared with the alternative compendial method of testing the entirety of the device. By focusing on the device feature(s), the most challenging validation variables can be isolated to and studied at the most difficult-to-clean feature(s). The device feature approach can be used to develop a design feature database that can be used to design and validate device cleanliness. It can also be used to commensurately develop a quantitative cleaning classification system that will augment and innovate the effectiveness of the Spaulding classification for microbial risk reduction. The current study investigated this validation approach to verify the efficacy of device cleaning procedures and mitigate patient risk. This feature categorization approach will help to close the existing patient safety gap at the important interface between device manufacturers and healthcare facilities for the effective and reliable processing of reusable medical devices. A total of 56,000 flushes of the device features were conducted, highlighting the rigor associated with the validation. Generating information from design features as a critical control point for cleaning and microbiological quality will inform future digital transformation of the medical device industry and healthcare delivery, including automation.
P. L. Chong, Joon Huang Chuah, C. Chow et al.
International Journal of Green Energy · 2024
ABSTRACT This review delves into the multifaceted landscape of plant microbial fuel cells (PMFCs), investigating the affecting factors, configurations, applications, challenges, and prospects that shape their design. A thorough exploration of the affecting factors covering natural factors such as type of living plants, type of microbes and environmental factors as well as man-made factors such as electrode material and design, addition of additives and the diverse array of PMFC configurations are investigated here. The configurations cover the tubular design, flat plate design, sediment type, green rooftop design, constructed wetland and bryophyte PMFC are analyzed for performance comparison, offering insights for researchers. Applications of PMFC for powering ultra-low power remote devices and sensors, biosensing purposes, wastewater treatment, to bioremediation of polluted sites, are showcased to show the versatility of PMFCs. Despite their promise, challenges such as low power output, plant selection and growth, control over microbial species, diversity and electron transfer mechanisms, the long-term stability and durability of PMFC as well as scalability and cost for wide implementation of PMFC, are conversed here as it necessitates innovative solutions. In addition, this paper also provides recommendation of prospects to be considered by future researchers to enhance the development of PMFC.
Yuvraj Maphrio Mao, Aarya Garg, Khairunnisa Amreen et al.
2023 16th International Conference on Sensing Technology (ICST) · 2023
Fiber-based Microbial Fuel Cells (MFCs) are emerging as promising technology in the field of fuel cells. Due, to the features like its inexpensive nature, naivety in fabrication, and its abundance of availability they manifest an upper edge over the other fluidic-based MFCs. Fiber-based MFCs are the epitome of an electrochemical system that uses bacteria for power generation and wastewater treatment in the paper substrate. Fiber-based miniaturized devices have gained significant attention over the last few years due to their flexible application in medical science, biosensors, etc. This work fabricated paper-based miniaturized MFCs using a 3D printer. Carbon Cloth was used as the working electrode and Pseudomonas Aeruginosa (Pseudomonas A) as the fuel to generate power. A comparative study showed that the fiber treated in oxygen plasma showed an optimized power output of around 345.40 µW/cm2 and a current output of 20.95 µA/cm2.
A. Mohamed, T. Ewing, S. Lindemann et al.
Journal of The Electrochemical Society · 2017
The performance of sediment microbial fuel cells (SMFCs) in the field must be evaluated prior to their being relied on as a power source for sensor networks. Currently, the ability to perform such evaluation is limited. The goal of this work was to develop an autonomous, battery-powered, low-cost device (a remote sediment microbial fuel cell tester, or RSMFCT) that can evaluate the field performance of SMFCs charging capacitors in remote areas. The developed RSMFCT allows an SMFC to charge a capacitor between preset charge and discharge potentials and monitors anode and cathode potentials, capacitor potential, and temperature. The RSMFCT was tested at a remote location in the Hot Lake Research Natural Area, near Oroville,WA, USA and used to evaluate the optimum conditions for operating an SMFC. Using the recorded data, the average power and frequency of cycle were determined. We found that SMFCs deployed in Hot Lake operated optimally when charging a 5-F capacitor from 300 mV to 400 mV. Under these conditions, the SMFCs produced an average daily power of 10.28 μW and required an average capacitor charging time of 3.08 hours. We conclude that the RSMFCT is practical for: 1) determining the optimum operation parameters, those that maximize the power output of SMFCs in field operation, and 2) reliably incorporating individual SMFCs as power sources for remote sensor networks by allowing the prediction of their power output and frequency of charge cycles. © The Author(s) 2016. Published by ECS. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License (CC BY, http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse of the work in any medium, provided the original work is properly cited. [DOI: 10.1149/2.0041703jes] All rights reserved.
I. Sulaiman, P. Banerjee, Ying-hsin Hsieh et al.
Journal of AOAC INTERNATIONAL · 2018
Staphylococcus spp. is considered as one of the most common human-pathogenic bacteria, causing illnesses ranging from nonthreatening skin infections to lethal diseases, including sepsis, pneumonia, bloodstream infections, and food poisoning. The emergence of methicillin-resistant Staphylococcus aureus strains has increased morbidity and mortality and resulted in a major healthcare burden worldwide. Single and multilocus sequence typing have been extensively used in the identification of Staphylococcus species. Nevertheless, these assays are relatively time-consuming and require high-quality DNA. Matrix-assisted laser desorption ionization-time-of-flight has been used recently for the rapid identification of several bacterial species. In this study, we have examined 47 Staphylococcus isolates recovered from food, environment, clinical samples, cosmetic products, and a medical device and 3 American Type Culture Collection Staphylococcus reference isolates using bioMérieux VITEK MS and VITEK 2 systems to determine isolate identity. Sequencing of the 16S ribosomal RNA gene was performed to confirm and compare the species identification data generated by VITEK 2 and VITEK MS systems. Although the VITEK 2 system could not identify one of the isolates, VITEK MS identified all 50 Staphylococcus spp. isolates tested. Results of this study clearly suggest that VITEK MS can be used in the rapid identification of Staphylococcus isolates of public health importance.
Shi-Hang Wang, Jian-Wei Wang, Li-ting Zhao et al.
Biosensors · 2023
Soil microbial fuel cells (SMFCs) are an innovative device for soil-powered biosensors. However, the traditional SMFC sensors relied on anodic biosensing which might be unstable for long-term and continuous monitoring of toxic pollutants. Here, a carbon-felt-based cathodic SMFC biosensor was developed and applied for soil-powered long-term sensing of heavy metal ions. The SMFC-based biosensor generated output voltage about 400 mV with the external load of 1000 Ω. Upon the injection of metal ions, the voltage of the SMFC was increased sharply and quickly reached a stable output within 2~5 min. The metal ions of Cd2+, Zn2+, Pb2+, or Hg2+ ranging from 0.5 to 30 mg/L could be quantified by using this SMFC biosensor. As the anode was immersed in the deep soil, this SMFC-based biosensor was able to monitor efficiently for four months under repeated metal ions detection without significant decrease on the output voltage. This finding demonstrated the clear potential of the cathodic SMFC biosensor, which can be further implemented as a low-cost self-powered biosensor.
Roszita Ibrahim, N. Shaari, Azana Hafizah Mohd Aman
International Journal of Energy Research · 2021
Fuel cells efficiently turn chemicals in fuel into electricity by chemical reaction and have been described as among the most recent advances in the upcoming cleaner energy sector. In recent times, fuel cells are being used in medicine, including experimental studies and current and potential goods, having numerous benefits over previous batteries, such as the convenience of recharging, eco‐sustainable character, and high safety. This article highlights the up‐to‐date development of this energy system focusing on biofuel cells in implantable medical devices (IMDs) that use microbes, enzymes, and noble metals as catalysts. Furthermore, a diversity of fuel cell applications on the vitro medical kit (including alcohol tester, wound treatment instrument, blood glucose meter) was also described. The integration of fuel cells into implementable medical devices is at an initial phase of research, but this technology's possibility and potency is a reward. Obviously, after successfully integrating fuel cells into the patient's psyche, civilization will move throughout an innovative diagnostic transition.
Mummaka Harshavardhan, Prashant Sakhavalkar, Attarde Viren Bhaskar
International Journal of Medical and Biomedical Studies · 2024
Background: Medical device-associated infections (MDAIs) are a major healthcare concern due to their high morbidity, mortality, and rising prevalence of MDR and XDR bacteria. This study examined the microbiological composition, antimicrobial susceptibility, and prevalence of MDR/XDR infections in MDAI patients at Dr. D.Y. Patil Medical College, Pune. Methods: One-year retrospective research included 100 MDAI patients. Antimicrobial susceptibility testing was done on microbial isolates from blood, urine, and wound swabs according to CLSI standards. The prevalence of MDR and XDR pathogens was determined. Results: Escherichia coli (30%) and Klebsiella pneumoniae (20%) caused most infections, while Staphylococcus aureus (25%) was the most common Gram-positive bacteria. Antimicrobial susceptibility testing showed that 40% of the isolates were MDR and 15% were XDR. Klebsiella pneumoniae had the highest resistance rate (70%), followed by Pseudomonas aeruginosa. Conclusion: The study shows that MDAIs are dominated by MDR and XDR infections, mainly Gram-negative bacteria, making therapy difficult. These findings highlight the critical need for improved infection control, antimicrobial stewardship, and regular surveillance to address medical device-associated resistance infections. Keywords: Medical device infections, multidrug-resistant, extensively drug-resistant organisms, antimicrobial susceptibility, microbiological profile, healthcare-associated infections.
Akanksha Mishra, Ashish Aggarwal, Fazlurrahman Khan
Antibiotics · 2024
Hospital-acquired infections, also known as nosocomial infections, include bloodstream infections, surgical site infections, skin and soft tissue infections, respiratory tract infections, and urinary tract infections. According to reports, Gram-positive and Gram-negative pathogenic bacteria account for up to 70% of nosocomial infections in intensive care unit (ICU) patients. Biofilm production is a main virulence mechanism and a distinguishing feature of bacterial pathogens. Most bacterial pathogens develop biofilms at the solid-liquid and air-liquid interfaces. An essential requirement for biofilm production is the presence of a conditioning film. A conditioning film provides the first surface on which bacteria can adhere and fosters the growth of biofilms by creating a favorable environment. The conditioning film improves microbial adherence by delivering chemical signals or generating microenvironments. Microorganisms use this coating as a nutrient source. The film gathers both inorganic and organic substances from its surroundings, or these substances are generated by microbes in the film. These nutrients boost the initial growth of the adhering bacteria and facilitate biofilm formation by acting as a food source. Coatings with combined antibacterial efficacy and antifouling properties provide further benefits by preventing dead cells and debris from adhering to the surfaces. In the present review, we address numerous pathogenic microbes that form biofilms on the surfaces of biomedical devices. In addition, we explore several efficient smart antiadhesive coatings on the surfaces of biomedical device-relevant materials that manage nosocomial infections caused by biofilm-forming microbial pathogens.
D. Roxby, Nham Tran, Pak-Lam Yu et al.
2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · 2016
Implanted biomedical devices typically last a number of years before their batteries are depleted and a surgery is required to replace them. A Microbial Fuel Cell (MFC) is a device which by using bacteria, directly breaks down sugars to generate electricity. Conceptually there is potential to continually power implanted medical devices for the lifetime of a patient. To investigate the practical potential of this technology, H-Cell Dual Chamber MFCs were evaluated with two different growth solutions and measurements recorded for maximum power output both of individual MFCs and connected MFCs. Using Luria-Bertani media and connecting MFCs in a hybrid series and parallel arrangement with larger membrane sizes showed the highest power output and the greatest potential for replacing implanted batteries.
Siyang Shen, Yen‐Han Lin, Chenguang Liu
The Canadian Journal of Chemical Engineering · 2024
Abstract In this work, we demonstrate a novel design that integrates a modified Nernst equation and readings from a microbial fuel cell (MFC)‐based device, facilitating real‐time monitoring of microbial growth. The MFC‐based device is comprised of an H‐shaped double‐chamber MFC, specifically designed to incorporate an oxidation–reduction potential (ORP) sensor, allowing for simultaneous measurements of both parameters. The Nernst equation was adjusted to assimilate readings from both the ORP sensor and the MFC device, ultimately deriving a unitless curve that represents the online dynamics of microbial growth. This curve exhibits two distinct peaks: the first peak indicates the initiation of the exponential phase, while the second peak signals its termination. The proposed design can be seamlessly integrated into fermentation processes to continually monitor progress, boost productivity, develop tailored control strategies that meet specific objectives, and so on.
Dawid Zawadzki, Paulina Pędziwiatr, Karina Michalska
Acta Innovations · 2018
Research about exploitation the potential of waste and sludge increased drastically in the recent years. One of the most promising alternative methods of waste management is Microbial Fuel Cell (MFC), which generate clean bio-electricity using microorganisms. Organic compounds, sewage, municipal solid waste could be used as a source for microbial nutrition. The construction of MFC is one of the most important parameter in laboratory studies and during scale-up. The efficiency of MFC depends on many factors including type of membrane. To obtain optimization in terms of various operating conditions, a prototype of Microbial Fuel Cell with exchangeable membrane was projected and fabricated by additive manufacturing (AM) technology. This novel device allows to research effects of different types of separator membranes. Preliminary research showed possibility to produce 3D printed MFC systems.
S. Abou Fayssal, Z. El Sebaaly, Y. Sassine
Foods · 2023
The short shelf-life of mushrooms, due to water loss and microbial spoilage, is the main constraint for commercialization and consumption. The effect of substrate type combined with different temperatures and packaging conditions on the shelf-life of fresh Pleurotus ostreatus is scantily researched. The current study investigated the shelf-life of fresh oyster mushrooms grown on low (0.3, 0.3, 0.17) and high (0.7, 0.7, 0.33) rates of olive pruning residues (OLPR), spent coffee grounds (SCG), and both combined residues (OLPR/SCG) with wheat straw (WS), respectively, at ambient (20 °C) and 4 °C temperatures under no packaging, polyethylene plastic bag packaging (PBP), and polypropylene vacuum bag packaging (VBP). Results showed that at ambient temperature OLPR/SCG mushrooms PBP-bagged had an increased shelf-life by 0.5–1.2 days in comparison with WS ones. The predictive models adopted to optimize mushroom shelf-life at ambient temperature set rates of 0.289 and 0.303 of OLPR and OLPR/SCG, respectively, and PBP as the most suitable conditions (9.18 and 9.14 days, respectively). At 4 °C, OLPR/SCG mushrooms VBP-bagged had a longer shelf-life of 2.6–4.4 days compared to WS ones. Predictive models noted a maximized shelf-life of VBP-bagged mushrooms (26.26 days) when a rate of 0.22 OLPR/SCG is incorporated into the initial substrate. The combination of OLPR and SCG increased the shelf-life of fresh Pleurotus ostreatus by decreasing the total microbial count (TMC) while delaying weight loss and veil opening, and maintaining carbohydrate content, good firmness, and considerable protein, in comparison with WS regardless the storage temperature and packaging type.
M. S. Santos, M. Nogueira, M. Hungria
AMB Express · 2019
More than one hundred years have passed since the development of the first microbial inoculant for plants. Nowadays, the use of microbial inoculants in agriculture is spread worldwide for different crops and carrying different microorganisms. In the last decades, impressive progress has been achieved in the production, commercialization and use of inoculants. Nowadays, farmers are more receptive to the use of inoculants mainly because high-quality products and multi-purpose elite strains are available at the market, improving yields at low cost in comparison to chemical fertilizers. In the context of a more sustainable agriculture, microbial inoculants also help to mitigate environmental impacts caused by agrochemicals. Challenges rely on the production of microbial inoculants for a broader range of crops, and the expansion of the inoculated area worldwide, in addition to the search for innovative microbial solutions in areas subjected to increasing episodes of environmental stresses. In this review, we explore the world market for inoculants, showing which bacteria are prominent as inoculants in different countries, and we discuss the main research strategies that might contribute to improve the use of microbial inoculants in agriculture.
Kevin Tian Xiang Tong, I. Tan, H. Foo et al.
Bioengineered · 2023
ABSTRACT The imminent need for transition to a circular biorefinery using microbial fuel cells (MFC), based on the valorization of renewable resources, will ameliorate the carbon footprint induced by industrialization. MFC catalyzed by bioelectrochemical process drew significant attention initially for its exceptional potential for integrated production of biochemicals and bioenergy. Nonetheless, the associated costly bioproduct production and slow microbial kinetics have constrained its commercialization. This review encompasses the potential and development of macroalgal biomass as a substrate in the MFC system for L-lactic acid (L-LA) and bioelectricity generation. Besides, an insight into the state-of-the-art technological advancement in the MFC system is also deliberated in detail. Investigations in recent years have shown that MFC developed with different anolyte enhances power density from several µW/m2 up to 8160 mW/m2. Further, this review provides a plausible picture of macroalgal-based L-LA and bioelectricity circular biorefinery in the MFC system for future research directions. Graphical Abstract
Dileep Sai Kumar Palur, Shannon R Pressley, S. Atsumi
Molecules · 2023
Human milk oligosaccharides (HMOs) are complex nonnutritive sugars present in human milk. These sugars possess prebiotic, immunomodulatory, and antagonistic properties towards pathogens and therefore are important for the health and well-being of newborn babies. Lower prevalence of breastfeeding around the globe, rising popularity of nutraceuticals, and low availability of HMOs have inspired efforts to develop economically feasible and efficient industrial-scale production platforms for HMOs. Recent progress in synthetic biology and metabolic engineering tools has enabled microbial systems to be a production system of HMOs. In this regard, the model organism Escherichia coli has emerged as the preferred production platform. Herein, we summarize the remarkable progress in the microbial production of HMOs and discuss the challenges and future opportunities in unraveling the scope of production of complex HMOs. We focus on the microbial production of five HMOs that have been approved for their commercialization.